UPDATE : Monday, September 7, 2020
상단여백
Physicians call for tighter control of botulinum toxin strains
The medical community has come forth to urge the health authorities to moni...
by So Jae-hyeon  |  2018-04-12 16:33
라인
Daewoong opens biotech research lab in Indonesia
Daewoong Pharmaceutical said it has established a biotech research center a...
by So Jae-hyeon  |  2018-04-12 11:37
라인
Software expert to head Veeva Systems Korea
Veeva Systems Korea, a cloud-based software provider for pharmaceutical and...
by So Jae-hyeon  |  2018-04-10 16:14
라인
LG Chem, Merck to co-market hypertension drug
LG Chem and Merck Biopharma Korea said Monday the two firms agreed to sell ...
by So Jae-hyeon  |  2018-04-10 15:15
라인
Biotech CEOs roll up sleeves for global biz
CEOs of Korea’s major biotech companies are directly involving in marketing...
by So Jae-hyeon  |  2018-04-10 12:09
라인
Tamiflu crushed generic copies in flu season
Despite the massive release of generic copies with the expiration of Tamifl...
by So Jae-hyeon  |  2018-04-09 15:40
라인
Biosimilars take on original at breast cancer conference
Industry officials said they were able to witness the advent of biosimilar ...
by So Jae-hyeon  |  2018-04-09 15:05
라인
Janssen, Hanmi start phase-2 study on obesity, diabetes drug
Janssen and Hanmi Pharmaceutical will start a global phase-2 clinical trial...
by So Jae-hyeon  |  2018-04-05 15:06
라인
Korean biosimilars rarely prescribed in US
Korean biosimilar products are still struggling to penetrate the U.S. marke...
by So Jae-hyeon  |  2018-04-05 15:05
라인
Will SGLT-2 combos with DPP-4 win insurance coverage?
Suppliers of antidiabetic medicines are paying attention to whether SGLT-2 ...
by So Jae-hyeon  |  2018-04-04 15:12
라인
Outpatient drug prescriptions plunged in February
The outpatient drug prescriptions market saw a drastic contraction in Febru...
by So Jae-hyeon  |  2018-04-03 16:59
라인
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon  |  2018-04-03 11:58
라인
Chinese lab ends Olita deal with Hanmi
China’s biotech firm Zai Lab has returned the exclusive sales license of an...
by So Jae-hyeon  |  2018-04-02 11:39
라인
Daewoong, Yuhan in new rivalry to sell antidiabetic drugs
Daewoong Pharmaceutical and Yuhan Corp, both boasting strong marketing powe...
by So Jae-hyeon  |  2018-03-30 16:23
라인
Dongkoo Bio inks deal to sell OTC prostate drug   
Dongkoo Bio & Pharma said it has signed a licensing-in deal with Swedish dr...
by So Jae-hyeon  |  2018-03-29 14:18
라인
Drugmakers step up anti-fine dust marketing
Pharmaceutical companies are focusing their marketing activities on fightin...
by So Jae-hyeon  |  2018-03-28 11:35
라인
Drugmakers seek partners to boost diabetes business
Pharmaceutical companies are seeking new partners to boost drug sales in th...
by So Jae-hyeon  |  2018-03-26 12:33
라인
Pharmicell aims to test dendritic cell-based cancer drug this year
A local stem cell developer has raised a possibility that dendritic cells m...
by So Jae-hyeon  |  2018-03-23 16:41
라인
Myongji Hospital, Cancer Rop team up to fight cancer
Myongji Hospital and Cancer Rop, a biotech firm formerly known as MGMed, ce...
by So Jae-hyeon  |  2018-03-23 15:48
라인
Anticoagulant latecomer Lixiana outrivals Eliquis
The competition between No.2 and No.3 next-generation anticoagulant is heat...
by So Jae-hyeon  |  2018-03-22 16:12
여백
여백
여백
Back to Top